Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
KY100001 / KPC Pharma
NCT04906473: Safety,Tolerability, Pharmacokinetic,Pharmacodynamics and Efficacy of KY100001 in Patients With Advanced Solid Tumors	Not yet recruiting	1	109	NA	KY100001	Kunming Pharmaceuticals, Inc.	Advanced Solid Tumor	12/22	10/23
SPX-101 / SparX
NCT05231733: Study of SPX-101 in Subjects With Advanced or Refractory Solid Tumors	Withdrawn	1	27	NA	SPX-101	SparX Biotech(Jiangsu) Co., Ltd.	Solid Tumors	04/24	08/24